Reilly Clifford A, Backer Grant, Basta Danielle, Riblet Natalie B V, Hofley Pamela M, Gallagher Megan C
From Education Division, The Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, New Hampshire.
Allergy Asthma Proc. 2018 Nov 1;39(6):420-429. doi: 10.2500/aap.2018.39.4178.
The majority of patients for elective surgery and with a history of penicillin allergy are placed on alternative prophylactic antibiotic therapies, which have been associated with the emergence of multidrug-resistant pathogens and increased morbidity and mortality rates. However, self-reporting of penicillin allergy alone may overestimate the prevalence of penicillin allergy in the population. To assess the effects of preoperative antibiotic allergy testing protocols in reducing the use of non-beta-lactam antibiotics. We searched medical literature data bases through July of 2018. Two reviewers independently extracted data from published studies and assessed the risk of bias in cohort studies by using the Newcastle-Ottawa Scale. We collected information related to study design, methodology, demographics, interventions, and outcomes. We pooled odds ratios for the rate of prescribing non-beta-lactam antibiotics by using a fixed-effects model. Of 905 citations screened for eligibility, nine studies met inclusion criteria for qualitative analysis. Studies reported that the rates of non-beta-lactam use after preoperative skin testing ranged from 6 to 30%. In addition, four of the nine studies had sufficient control data to be included in a meta-analysis. These four studies found that preoperative testing protocols significantly decreased the rates of prescribing non-beta-lactam antibiotics compared with usual care (odds ratio 3.64 [95% confidence interval, 2.67-4.98]; < 0.0001). Seven studies reported on adverse drug reactions after preoperative skin testing and found that the rate of such reactions was rare. Preoperative antibiotic allergy testing protocols seemed to be a safe and effective tool in reducing the use of non-beta-lactam antibiotics during surgery.
大多数接受择期手术且有青霉素过敏史的患者会接受替代预防性抗生素治疗,而这与多重耐药病原体的出现以及发病率和死亡率的增加有关。然而,仅通过自我报告青霉素过敏可能会高估人群中青霉素过敏的患病率。为了评估术前抗生素过敏测试方案在减少非β-内酰胺类抗生素使用方面的效果。我们检索了截至2018年7月的医学文献数据库。两名评审员独立从已发表的研究中提取数据,并使用纽卡斯尔-渥太华量表评估队列研究中的偏倚风险。我们收集了与研究设计、方法、人口统计学、干预措施和结果相关的信息。我们使用固定效应模型汇总了开具非β-内酰胺类抗生素的比值比。在筛选的905篇符合条件的文献中,有9项研究符合定性分析的纳入标准。研究报告称,术前皮肤测试后非β-内酰胺类抗生素的使用率在6%至30%之间。此外,9项研究中有4项有足够的对照数据可纳入荟萃分析。这4项研究发现,与常规护理相比,术前测试方案显著降低了开具非β-内酰胺类抗生素的比例(比值比3.64 [95%置信区间,2.67 - 4.98];P < 0.0001)。7项研究报告了术前皮肤测试后的药物不良反应,发现此类反应的发生率很低。术前抗生素过敏测试方案似乎是一种在手术期间减少非β-内酰胺类抗生素使用的安全有效的工具。